Community Trust & Investment Co Has Trimmed Markel (MKL) Holding By $348,909; Kazazian Asset Management Lifted Its Clovis Oncology (CLVS) Position

February 15, 2018 - By Peter Erickson

Kazazian Asset Management Llc increased Clovis Oncology Inc (CLVS) stake by 55.3% reported in 2017Q3 SEC filing. Kazazian Asset Management Llc acquired 6,229 shares as Clovis Oncology Inc (CLVS)’s stock declined 20.61%. The Kazazian Asset Management Llc holds 17,493 shares with $1.44M value, up from 11,264 last quarter. Clovis Oncology Inc now has $2.68 billion valuation. The stock increased 1.13% or $0.61 during the last trading session, reaching $54.7. About 427,562 shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since February 15, 2017 and is uptrending. It has outperformed by 266.01% the S&P500.

Community Trust & Investment Co decreased Markel Corporation (MKL) stake by 1.73% reported in 2017Q3 SEC filing. Community Trust & Investment Co sold 327 shares as Markel Corporation (MKL)’s stock declined 1.12%. The Community Trust & Investment Co holds 18,624 shares with $19.89 million value, down from 18,951 last quarter. Markel Corporation now has $15.65 billion valuation. The stock increased 1.05% or $11.71 during the last trading session, reaching $1126.72. About 7,991 shares traded. Markel Corporation (NYSE:MKL) has declined 1.06% since February 15, 2017 and is downtrending. It has underperformed by 17.76% the S&P500.

Among 4 analysts covering Markel Corporation (NYSE:MKL), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Markel Corporation had 11 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Hold” rating by RBC Capital Markets on Monday, July 10. The stock of Markel Corporation (NYSE:MKL) earned “Hold” rating by SunTrust on Friday, October 27. On Thursday, July 27 the stock rating was maintained by RBC Capital Markets with “Hold”. The rating was upgraded by William Blair on Thursday, April 14 to “Outperform”. SunTrust maintained the stock with “Neutral” rating in Thursday, August 4 report. The firm has “Hold” rating given on Monday, October 2 by RBC Capital Markets. RBC Capital Markets downgraded the shares of MKL in report on Friday, August 7 to “” rating. The stock has “Hold” rating by SunTrust on Wednesday, February 7. RBC Capital Markets maintained Markel Corporation (NYSE:MKL) rating on Monday, August 28. RBC Capital Markets has “Hold” rating and $1050.0 target. The stock of Markel Corporation (NYSE:MKL) earned “Hold” rating by RBC Capital Markets on Wednesday, February 7.

Community Trust & Investment Co increased Lowes Cos Inc (NYSE:LOW) stake by 64,015 shares to 212,853 valued at $17.02M in 2017Q3. It also upped Pioneer Natural Resources Co (NYSE:PXD) stake by 29,071 shares and now owns 98,207 shares. Johnson Controls International was raised too.

Investors sentiment increased to 1.17 in Q3 2017. Its up 0.11, from 1.06 in 2017Q2. It improved, as 29 investors sold MKL shares while 109 reduced holdings. 42 funds opened positions while 119 raised stakes. 10.44 million shares or 0.15% more from 10.42 million shares in 2017Q2 were reported. Loring Wolcott And Coolidge Fiduciary Advsrs Limited Liability Partnership Ma, a Massachusetts-based fund reported 2 shares. Alexandria Cap Limited Liability Co reported 34 shares. Vnbtrust Natl Association holds 0.1% or 233 shares. 58,489 were reported by Douglass Winthrop Lc. 512 were reported by Global X Llc. Valley Advisers has invested 0.01% in Markel Corporation (NYSE:MKL). 14,465 were accumulated by Sather Fincl Group Inc Inc. Sterling Mgmt Lc reported 72,063 shares. Essex Fincl stated it has 0.18% of its portfolio in Markel Corporation (NYSE:MKL). Federated Invsts Pa holds 0% or 1 shares. Union Comml Bank stated it has 0.16% of its portfolio in Markel Corporation (NYSE:MKL). Schwab Charles Inv Mgmt invested 0.03% in Markel Corporation (NYSE:MKL). Df Dent And has invested 2.57% in Markel Corporation (NYSE:MKL). Ancora Advsrs Ltd Limited Liability Company invested in 0.01% or 189 shares. Raymond James & has invested 0.04% in Markel Corporation (NYSE:MKL).

Since August 14, 2017, it had 0 insider buys, and 10 selling transactions for $2.26 million activity. Crowley F. Michael also sold $316,254 worth of Markel Corporation (NYSE:MKL) shares. MARKEL STEVEN A also sold $213,514 worth of Markel Corporation (NYSE:MKL) shares. $105,020 worth of Markel Corporation (NYSE:MKL) shares were sold by Whitt Richard R III. $107,770 worth of Markel Corporation (NYSE:MKL) shares were sold by KIRSHNER ALAN I.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 70% are positive. Clovis Oncology had 56 analyst reports since September 10, 2015 according to SRatingsIntel. Credit Suisse upgraded Clovis Oncology, Inc. (NASDAQ:CLVS) on Wednesday, September 21 to “Outperform” rating. Morgan Stanley maintained Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Thursday, November 2. Morgan Stanley has “Overweight” rating and $86 target. The rating was downgraded by Goldman Sachs on Tuesday, November 17 to “Neutral”. The company was upgraded on Wednesday, May 17 by JP Morgan. The rating was initiated by Bank of America on Friday, January 27 with “Buy”. The stock has “Buy” rating by WallachBeth Capital on Thursday, September 10. The stock of Clovis Oncology, Inc. (NASDAQ:CLVS) earned “Neutral” rating by Piper Jaffray on Monday, April 4. Leerink Swann maintained Clovis Oncology, Inc. (NASDAQ:CLVS) on Monday, July 31 with “Buy” rating. The firm has “Buy” rating by Stifel Nicolaus given on Monday, January 23. The stock has “Hold” rating by WallachBeth Capital on Wednesday, December 21.

Investors sentiment decreased to 1.44 in 2017 Q3. Its down 0.37, from 1.81 in 2017Q2. It turned negative, as 48 investors sold CLVS shares while 49 reduced holdings. 42 funds opened positions while 98 raised stakes. 47.46 million shares or 2.14% more from 46.46 million shares in 2017Q2 were reported. Boston Advsrs Ltd Liability Com invested in 0.25% or 136,115 shares. Kingdon Ltd Liability Com stated it has 155,962 shares. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% in Clovis Oncology, Inc. (NASDAQ:CLVS). Venbio Select Advisor Ltd Llc invested in 785,700 shares. Sector Gamma As has invested 1.86% in Clovis Oncology, Inc. (NASDAQ:CLVS). Weiss Multi holds 0.09% or 30,000 shares in its portfolio. Opus Point Prtnrs Mgmt Lc invested in 15,000 shares or 1.11% of the stock. 51,700 are held by Numeric Investors Llc. Atwood & Palmer Incorporated reported 100 shares or 0% of all its holdings. New York-based American Intll Grp has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Great West Life Assurance Can reported 0% in Clovis Oncology, Inc. (NASDAQ:CLVS). Hudson Bay Capital Mngmt LP reported 0.08% in Clovis Oncology, Inc. (NASDAQ:CLVS). Nokota Limited Partnership stated it has 0.21% in Clovis Oncology, Inc. (NASDAQ:CLVS). Granite Point Cap Mgmt LP has invested 0.53% in Clovis Oncology, Inc. (NASDAQ:CLVS). Nationwide Fund Advsrs accumulated 161,958 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: